PHGE - BiomX Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD

BiomX Inc.

7 Pinhas Sapir Street
2nd Floor
Ness Ziona 7414002
972 7 23942377

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan Eitan Solomon MBACEO & DirectorN/AN/A1977
Prof. Rotem SorekScientific FounderN/AN/AN/A
Dr. Eran ElinavScientific FounderN/AN/AN/A
Prof. Timothy K. LuScientific FounderN/AN/AN/A
Ms. Marina WolfsonVP of Fin. & Operations and CFON/AN/A1985
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BiomX Inc., a clinical-stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from dysbiosis of the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases, primary sclerosing cholangitis, and cancer. The company is based in Ness Ziona, Israel.

Corporate Governance

BiomX Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.